MSMKF: AI 评分 49/100 — AI 分析 (4月 2026)

MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies across Japan. With a history dating back to 1932, the company has established a significant presence in the Japanese healthcare retail market.

Key Facts: AI Score: 49/100 Sector: Healthcare

公司概况

概要：

MatsukiyoCocokara & Co. is a leading drug store and pharmacy chain in Japan, operating over 1,700 stores across 47 prefectures. With a focus on healthcare retail, the company leverages its extensive network and established brand to serve a broad customer base in the Japanese market.

MSMKF是做什么的？

MatsukiyoCocokara & Co. was founded in 1932 and has grown to become a prominent drug store and pharmacy chain in Japan. The company operates a network of 1,726 stores as of June 30, 2020, spanning all 47 prefectures of Japan. These stores offer a wide range of products and services, including prescription drugs, over-the-counter medications, health and beauty products, and daily necessities. MatsukiyoCocokara & Co. aims to provide convenient access to healthcare and wellness products for its customers. The company has strategically expanded its store network and product offerings to meet the evolving needs of the Japanese market. MatsukiyoCocokara & Co. competes with other drug store chains and pharmacies in Japan, focusing on customer service, product selection, and store locations to maintain its competitive edge. The company is based in Matsudo, Japan, and continues to focus on strengthening its position in the Japanese healthcare retail sector.

MSMKF的投资论点是什么？

MatsukiyoCocokara & Co. presents a stable investment opportunity within the Japanese healthcare retail market. The company's established network of over 1,700 stores provides a strong foundation for consistent revenue generation. With a P/E ratio of 17.62 and a profit margin of 5.1%, the company demonstrates reasonable profitability. The dividend yield of 1.89% offers a steady income stream for investors. Growth catalysts include expanding product offerings and enhancing online presence. Potential risks include increasing competition from other drug store chains and evolving consumer preferences. The company's beta of -0.21 suggests low volatility compared to the broader market.

MSMKF在哪个行业运营？

MatsukiyoCocokara & Co. operates within the competitive Japanese healthcare retail market. The industry is characterized by a large number of drug store chains and pharmacies, all vying for market share. Key trends include an aging population, increasing healthcare awareness, and growing demand for health and beauty products. The company competes with other major players such as CSMYF, KYKOF, RADLY, SHTDF, and SHTDY. MatsukiyoCocokara & Co. differentiates itself through its extensive store network, product selection, and customer service.

Medical - Pharmaceuticals

Healthcare

MSMKF有哪些增长机遇？

Expanding online presence: MatsukiyoCocokara & Co. can capitalize on the growing e-commerce trend by expanding its online platform and offering online ordering and delivery services. This would allow the company to reach a broader customer base and increase sales. The e-commerce market in Japan is expected to continue growing, providing a significant opportunity for MatsukiyoCocokara & Co. to increase its market share. Timeline: Ongoing.
Increasing private label product offerings: MatsukiyoCocokara & Co. can increase its profitability by expanding its private label product offerings. Private label products typically have higher margins than branded products, allowing the company to improve its overall profitability. The market for private label products is growing in Japan, as consumers become more price-conscious. Timeline: Ongoing.
Strategic acquisitions: MatsukiyoCocokara & Co. can pursue strategic acquisitions to expand its store network and market share. Acquiring smaller drug store chains or pharmacies would allow the company to quickly increase its presence in new markets and gain access to new customers. The Japanese drug store market is fragmented, providing opportunities for consolidation. Timeline: Ongoing.
Focusing on preventative healthcare: MatsukiyoCocokara & Co. can capitalize on the growing trend of preventative healthcare by offering a wider range of preventative healthcare products and services. This could include vitamins, supplements, and health screenings. The market for preventative healthcare products and services is growing in Japan, as consumers become more health-conscious. Timeline: Ongoing.
Expanding into new geographic markets: MatsukiyoCocokara & Co. can explore opportunities to expand into new geographic markets outside of Japan. This would allow the company to diversify its revenue streams and reduce its reliance on the Japanese market. The global healthcare retail market is growing, providing opportunities for MatsukiyoCocokara & Co. to expand its international presence. Timeline: Future

Operates 1,726 stores across 47 prefectures in Japan as of June 30, 2020, providing extensive market coverage.
P/E ratio of 17.62 indicates a reasonable valuation compared to earnings.
Profit margin of 5.1% reflects the company's ability to generate profits from its operations.
Gross margin of 35.2% demonstrates effective cost management in product sales.
Dividend yield of 1.89% offers a consistent income stream for investors.

MSMKF提供哪些产品和服务？

Operates a chain of drug stores and pharmacies.
Sells prescription drugs.
Offers over-the-counter medications.
Provides health and beauty products.
Sells daily necessities.
Offers healthcare and wellness products.

MSMKF如何赚钱？

Generates revenue through the sale of products in its stores.
Prescription drug sales contribute a significant portion of revenue.
Over-the-counter medications and health/beauty products also drive sales.
The company leverages its store network to reach a broad customer base.

Individual consumers seeking healthcare and wellness products.
Patients requiring prescription medications.
Customers looking for over-the-counter remedies.
Individuals purchasing health and beauty products.

Extensive store network across Japan provides a competitive advantage.
Established brand reputation and customer loyalty.
Strong relationships with pharmaceutical suppliers.
Efficient supply chain and distribution network.

什么因素可能推动MSMKF股价上涨？

Upcoming: Expansion of online platform to increase reach and sales.
Ongoing: Increasing private label product offerings to improve profitability.
Ongoing: Strategic acquisitions to expand store network and market share.
Ongoing: Focusing on preventative healthcare to capitalize on growing trend.
Upcoming: Launch of new health and wellness product lines.

MSMKF的主要风险是什么？

Ongoing: Increasing competition from other drug store chains.
Potential: Changing consumer preferences and demand.
Potential: Economic slowdown impacting consumer spending.
Potential: Regulatory changes in the healthcare industry.
Ongoing: Dependence on the Japanese market.

MSMKF的核心优势是什么？

Extensive store network across Japan.
Established brand reputation.
Wide range of products and services.
Strong relationships with suppliers.

MSMKF的劣势是什么？

Reliance on the Japanese market.
Exposure to regulatory changes in the healthcare industry.
Competition from other drug store chains.
Vulnerability to economic downturns.

MSMKF有哪些机遇？

Expanding online presence.
Increasing private label product offerings.
Strategic acquisitions.
Focusing on preventative healthcare.

MSMKF面临哪些威胁？

Increasing competition.
Changing consumer preferences.
Economic slowdown.
Regulatory changes.

MSMKF的竞争对手是谁？

Cosmos Pharmaceutical Corporation — Focuses on low-price strategy and efficient operations. — (CSMYF)
Kusuri No Aoki Holdings Co Ltd — Operates drugstores and pharmacies with a focus on community healthcare. — (KYKOF)
Rite Aid Corporation — US-based drugstore chain with a focus on pharmacy services. — (RADLY)
Sundrug Co Ltd — Operates drugstores and pharmacies with a focus on customer service. — (SHTDF)
Sugi Holdings Co Ltd — Focuses on prescription drug sales and healthcare services. — (SHTDY)

Key Metrics

MoonshotScore: 49/100

Company Profile

CEO: Kiyoo Matsumoto
Headquarters: Matsudo, JP
Employees: 13,371
Founded: 2014

AI Insight

AI analysis pending for MSMKF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does MatsukiyoCocokara & Co. do?

MatsukiyoCocokara & Co. operates as a leading drug store and pharmacy chain in Japan. The company's core business involves retailing prescription drugs, over-the-counter medications, health and beauty products, and daily necessities through its extensive network of over 1,700 stores across 47 prefectures. The company aims to provide convenient access to healthcare and wellness products for its customers, focusing on customer service, product selection, and store locations to maintain its competitive edge in the Japanese market.

What do analysts say about MSMKF stock?

AI analysis is currently pending for MSMKF, therefore an analyst consensus is not available. However, key valuation metrics include a P/E ratio of 17.62 and a dividend yield of 1.89%. Growth considerations involve expanding online presence, increasing private label product offerings, and pursuing strategic acquisitions. Risks include increasing competition from other drug store chains and evolving consumer preferences. Investors should conduct their own due diligence and consider their individual investment objectives before making any decisions.

What are the main risks for MSMKF?

The main risks for MatsukiyoCocokara & Co. include increasing competition from other drug store chains in Japan, which could impact market share and profitability. Changing consumer preferences and demand for healthcare products also pose a risk. An economic slowdown could reduce consumer spending and negatively affect sales. Regulatory changes in the healthcare industry could impact the company's operations and profitability. Additionally, the company's dependence on the Japanese market exposes it to economic and political risks specific to Japan.